Melitta

Ethinylestradiol / Gestodene, the active ingredient in Melitta, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Melitta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melitta, a combined oral contraceptive, acts on the hormonal regulation of the menstrual cycle to prevent pregnancy.

- Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. - Menstrual cycle regulation: helps establish a predictable monthly cycle and reduce irregular bleeding. - Dysmenorrhea relief: lessens menstrual pain associated with ovulatory cycles.

Common side effects are generally mild and transient, reflecting the hormonal activity of the preparation.

Common Side Effects: - Nausea: mild stomach upset, often resolves with continued use. - Headache: tension‑type or migraine‑like discomfort. - Breast tenderness: temporary swelling or soreness. - Spotting or breakthrough bleeding: irregular bleeding between periods. - Weight fluctuation: mild fluid retention or appetite changes. - Mood changes: irritability or mild depressive symptoms.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Hypertensive crisis: sudden, severe increase in blood pressure. - Liver dysfunction: jaundice or abnormal liver enzymes. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Visual disturbances: blurred vision or retinal vein occlusion. - Gallbladder disease: inflammation or stones.

Before prescribing Melitta, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Contraindications: active thromboembolic disease, known estrogen‑dependent tumor, or severe uncontrolled hypertension. - Smoking: avoid in women over 35 who smoke, due to increased cardiovascular risk. - Liver disease: use with caution in patients with hepatic impairment. - Migraine with aura: consider alternative contraception because of stroke risk. - Medication adherence: missed tablets can reduce efficacy; advise on backup methods. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Melitta may interact with other medicines that affect hormone metabolism or clotting pathways.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): markedly reduce contraceptive effectiveness. - Anticoagulants (e.g., warfarin): may increase risk of thrombosis when combined with estrogen.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., sertraline): may slightly increase plasma hormone levels. - Antifungals (e.g., ketoconazole): can raise estrogen concentrations, potentially enhancing side effects. - Herbal supplements (e.g., St. John's wort): may modestly decrease contraceptive efficacy.